Q: Is there particular reason for Husky's share price to fall so sharply in the past few days with respect to the shares of another integrated producer like Suncor?
Thanks!
Thanks!
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: The trends at company and in apparel generally are distressing. Mall traffic over Thanksgiving in US, corroborated by a drop in gas consumption, was down. I've noticed that a number of malls' vacancy both sequentially and yoy is up. Reitmans e-commerce is great (or getting better) but its stores are seemingly always empty even if its recent marketing campaign was very fresh even exciting. I think its game over here.
Q: I notice that you have BEP rated as an "A". I am looking for diversification in my wife's portfolio, for safety and stability. I notice, however, that BEP has a very ugly chart for the past year and some disappointment re earnings reports. What is your present opinion of BEP?
Q: What is difference between real growth and organic growth? In a Nestle context (global company)
Q: Can you comment please?
Q: Its last quarter was a disaster. What is your outlook for this company?
Q: Can you provide update. Can't believe the vol.
Q: This security's price action continues to disappoint. Comments?
Q: I should increase our health,materials,and energy sectors.Could you give me a few suggestions.I plan to sell Spectra Energy (SE-N) and Power Financial (PWF-T) in the new year to make the purchases.
Thanks.
Thanks.
Q: Your views as to the growth and outlook of this company. tks
Q: The shock of its disappointing quarter was exacerbated by poor liquidity issues. Can we expect to see this stock, now in the sin box, recover? Any time line on banking license?
Q: Hi Peter & Co.,
I own 3000 shares of BRF.PR.F, preferreds which pay $1.25 each annually, or 5% of the original issue price.
Brookfield has offered a share exchange in which I would receive one new Class A, Series 5 preferred share unit for each of my current shares. The new units would pay 5.59% annually. Sounds good at first glance, but I am wondering why the company would do this, and whether there are other features of the new Class A, Series 5 units that are less desirable. My original cost for my shares is $19.84 each.
Can you comment please? Thanks!
Brian
I own 3000 shares of BRF.PR.F, preferreds which pay $1.25 each annually, or 5% of the original issue price.
Brookfield has offered a share exchange in which I would receive one new Class A, Series 5 preferred share unit for each of my current shares. The new units would pay 5.59% annually. Sounds good at first glance, but I am wondering why the company would do this, and whether there are other features of the new Class A, Series 5 units that are less desirable. My original cost for my shares is $19.84 each.
Can you comment please? Thanks!
Brian
Q: What a mess. Where is the bottom on this. Have to admit about throwing in towel. Its recent dividend announcement was especially disconcerting. The money flow is pathetic and management does not inspire.
Q: In your recent Canadian Money Saver article about using call options to enhance income in a US portfolio, you gave a few examples of securities that could be considered for this strategy. As someone who invests only in your BE and Income portfolios, are there any names in these that would be the type of company you would consider for the same strategy in Canada?
Thank you.
Thank you.
Q: I hold a small amount of AVO and SYZ in my TFSA. I've held both for about a year and I'm pretty much flat, up a little if I take into account SYZ dividend. My concern is that while I am happy with my sector weightings I hold 42 stocks and I'd like to start trimming that down to a more manageable level. As part of the downsizing I'd like to sell AVO and SYZ and add some CSU, ESL, or GOOGL which are already existing positions in my TFSA and each is up substantially since when I purchased them. Appreciate your advice.
Q: I like the Brookfield entities and have held them, in various forms, for well over a decade. I want to also like BEP, however, I don't understand something - their cash flow per unit has only increased by about 3% on average over the last three to four years. How can they and the market expect the kind of returns that many are anticipating (e.g. Scotia - 29% including 7.2% distribution) when the multiple isn't that compressed and the free cash flow isn't really growing? Thanks for the great service!
Q: Peter and His Wonder Team
On Nov.16th KGI bought SAS...to close in Jan.2016...if all proceeds well. SAS was valued at $0.47 and would receive .0906 KGI shares for each SAS share.
Currently SAS is trading at $0.44 and KGI is down from it's $5.23 closing on Nov.16th. My question if you please...is there any way SAS can go above $0.47 before the closing date? What happens if KGI went higher than $5.23 before closing...would that effect SAS?
Dr. Ernest Rivait
On Nov.16th KGI bought SAS...to close in Jan.2016...if all proceeds well. SAS was valued at $0.47 and would receive .0906 KGI shares for each SAS share.
Currently SAS is trading at $0.44 and KGI is down from it's $5.23 closing on Nov.16th. My question if you please...is there any way SAS can go above $0.47 before the closing date? What happens if KGI went higher than $5.23 before closing...would that effect SAS?
Dr. Ernest Rivait
Q: I have noticed that in some stocks there is significant exercise by insiders of options. I am wondering if this is because of statements made by the Liberals in the election about taxing options of high income earners. I would appreciate you thoughts.
Q: I notice that AW.UN is currently paying a monthly dividend of .1250 which equates to annual dividend of 1.50. Current EPS, TTM is only 1.32.
Based on this alone, they can't cover the dividend... am I missing something here?
Thanks!
Based on this alone, they can't cover the dividend... am I missing something here?
Thanks!
Q: I've been a long-term owner of Allergan. The potential deal with Pfizer indicates that 11.3 shares of PFE will be granted for every 1 share of AGN. Looking at the closing prices of each company on Friday Nov 4th, AGN closed at $316.50 and PFE closed at $32.80. At 11.3 shares of PFE per AGN, this currently values AGN at $360.80.
In your opinion, why are the AGN shares not trading around the value of the deal? Is there significant pessimism about the deal? Are the targets for PFE shares significantly lower over the next year?
Seems to me this is kind of a "back the truck up" opportunity...
Thanks!
In your opinion, why are the AGN shares not trading around the value of the deal? Is there significant pessimism about the deal? Are the targets for PFE shares significantly lower over the next year?
Seems to me this is kind of a "back the truck up" opportunity...
Thanks!